Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustrySplitsCorrelations

China SXT Pharmaceuticals (SXTC) Income Statement (2017 - 2025)

Annual Income Statement report data from Mar 31, 2017 to Mar 31, 2025 for China SXT Pharmaceuticals (SXTC).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
202520242023202220222021202120202020201920182017
Revenue and COGS
Total Revenue
1.74M
(-9.84%)
1.93M
(-2.03%)
1.97M
(-24.23%)
2.60M
(0.00%)
2.60M
(-45.61%)
4.78M
(0.00%)
4.78M
(-7.36%)
5.16M
(0.00%)
5.16M
(-26.39%)
7.01M
(-0.14%)
7.02M
(+43.85%)
4.88M
Cost Of Revenue
1.37M
(0.00%)
1.37M
(-11.61%)
1.55M
(+14.81%)
1.35M
(0.00%)
1.35M
(-30.41%)
1.94M
(0.00%)
1.94M
(-21.14%)
2.46M
(0.00%)
2.46M
(+2.50%)
2.40M
(-33.70%)
3.62M
(+40.86%)
2.57M
Costof Goods And Services Sold
1.37M
(0.00%)
1.37M
(-11.61%)
1.55M
(+14.81%)
1.35M
(0.00%)
1.35M
(-30.41%)
1.94M
(0.00%)
1.94M
(-21.14%)
2.46M
(0.00%)
2.46M
(+2.50%)
2.40M
(-33.70%)
3.62M
(+40.86%)
2.57M
Gross Profit
370K
(-32.73%)
550K
(+27.91%)
430K
(-65.60%)
1.25M
(0.00%)
1.25M
(-55.99%)
2.84M
(0.00%)
2.84M
(+5.19%)
2.70M
(0.00%)
2.70M
(-41.43%)
4.61M
(+35.59%)
3.40M
(+47.19%)
2.31M
Operating Expenses
Research And Development
-180K
(-10.00%)
200K
(-45.95%)
370K--------
Selling General And Administrative
2.76M
(+4.55%)
2.64M
(-53.27%)
5.65M
(+2.36%)
5.52M
(0.00%)
5.52M
(+60.00%)
3.45M
(0.00%)
3.45M
(+40.24%)
2.46M
(0.00%)
2.46M
(+98.39%)
1.24M
(-1.59%)
1.26M
(+121.05%)
570K
Operating Expenses
3.05M
(-0.65%)
3.07M
(-49.09%)
6.03M
(-6.37%)
6.44M
(0.00%)
6.44M
(+27.78%)
5.04M
(0.00%)
5.04M
(+24.75%)
4.04M
(0.00%)
4.04M
(+42.25%)
2.84M
(+60.45%)
1.77M
(+149.30%)
710K
Depreciation And Amortization
80K
(-60.00%)
200K
(-20.00%)
250K
(-21.88%)
320K
(0.00%)
320K
(-8.57%)
350K
(0.00%)
350K
(+6.06%)
330K
(0.00%)
330K
(+83.33%)
180K
(+38.46%)
130K
(+44.44%)
90K
Operating Income
Operating Income
-2.68M
(+6.35%)
-2.52M
(-55.08%)
-5.61M
(+8.09%)
-5.19M
(0.00%)
-5.19M
(+135.91%)
-2.20M
(0.00%)
-2.20M
(+64.18%)
-1.34M
(0.00%)
-1.34M1.77M
(+8.59%)
1.63M
(+1.88%)
1.60M
Ebit
-2.68M
(+6.35%)
-2.52M
(-55.08%)
-5.61M
(+8.09%)
-5.19M
(0.00%)
-5.19M
(+135.91%)
-2.20M
(0.00%)
-2.20M
(+64.18%)
-1.34M
(0.00%)
-1.34M1.77M
(+8.59%)
1.63M
(+1.88%)
1.60M
EBITDA
-2.60M
(+12.55%)
-2.31M
(-56.90%)
-5.36M
(+10.06%)
-4.87M
(0.00%)
-4.87M
(+163.24%)
-1.85M
(0.00%)
-1.85M
(+83.17%)
-1.01M
(0.00%)
-1.01M1.95M
(+10.80%)
1.76M
(+3.53%)
1.70M
Other Income / Expenses
Interest Expense
110K
(-52.17%)
230K
(-52.08%)
480K
(+1100.00%)
40K
(0.00%)
40K
(-97.53%)
1.62M
(0.00%)
1.62M
(-51.64%)
3.35M
(0.00%)
3.35M
(+33400.00%)
10K-40K
Net Interest Income
---480.00K
(+1100.00%)
-40.00K
(0.00%)
-40.00K
(-97.53%)
-1.62M
(0.00%)
-1.62M
(-51.64%)
-3.35M
(0.00%)
-3.35M
(+33400.00%)
-10.00K--40.00K
Other Non Operating Income
-620.00K
(+6.90%)
-580.00K150K-180.00K
(0.00%)
-180.00K870K
(0.00%)
870K-70.00K
(0.00%)
-70.00K30K-20K
Net Income
Income Before Tax
-3.30M
(+6.45%)
-3.10M
(-47.72%)
-5.93M
(+9.61%)
-5.41M
(0.00%)
-5.41M
(+84.01%)
-2.94M
(0.00%)
-2.94M
(-71.70%)
-10.39M
(0.00%)
-10.39M1.79M--
Income Tax Expense
---330K
(0.00%)
330K-190.00K
(0.00%)
-190.00K
(+90.00%)
-100.00K
(0.00%)
-100.00K250K
(-43.18%)
440K
(+10.00%)
400K
Net Income From Continuing Operations
-3.30M
(+6.45%)
-3.10M
(-47.72%)
-5.93M
(+3.31%)
-5.74M
(0.00%)
-5.74M
(+108.73%)
-2.75M
(0.00%)
-2.75M
(-73.28%)
-10.29M
(0.00%)
-10.29M1.54M
(+29.41%)
1.19M
(0.00%)
1.19M
Net Income
-3.30M
(+6.45%)
-3.10M
(-47.72%)
-5.93M
(+3.31%)
-5.74M
(0.00%)
-5.74M
(+108.73%)
-2.75M
(0.00%)
-2.75M
(-73.28%)
-10.29M
(0.00%)
-10.29M1.54M
(+29.41%)
1.19M
(0.00%)
1.19M
Comprehensive Income Net Of Tax
-3.35M
(-14.76%)
-3.93M
(-44.57%)
-7.09M
(+33.52%)
-5.31M
(0.00%)
-5.31M
(+225.77%)
-1.63M
(0.00%)
-1.63M
(-85.09%)
-10.93M
(0.00%)
-10.93M1.33M
(-6.99%)
1.43M
(+28.83%)
1.11M